n-formylmethionine leucyl-phenylalanine has been researched along with Malignant Melanoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, C; Fu, C; Guo, H; Liang, S; Long, M; Wagner, D; Zhan, D | 1 |
| Chapman, PB; Houghton, AN; Minasian, LM; Morrison, ME; Nathan, CF; Rosenblum, M; Steffens, T; Szatrowski, TP; Williams, L | 1 |
| Blaise, D; David, M; Fossat, C; Juhan-Vague, I; Maraninchi, D; Sainty, D; Stoppa, AM | 1 |
| Mrowietz, U; Müller, R; Zheng, M | 1 |
| Eckert, K; Heidecke, H; Maurer, HR; Schulze-Forster, K | 1 |
| Kapp, A; Komann, A; Schöpf, E | 1 |
| Gallati, H; Müller, R; Obrecht, JP; Obrist, R; Schmidli, J | 1 |
| Fidler, IJ; Morikawa, K; Nayar, R | 1 |
2 trial(s) available for n-formylmethionine leucyl-phenylalanine and Malignant Melanoma
| Article | Year |
|---|---|
Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; Gangliosides; Humans; Male; Melanoma; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Necrosis; Neutrophils; Recombinant Proteins; Tetradecanoylphorbol Acetate; Tumor Lysis Syndrome; Tumor Necrosis Factor-alpha | 1994 |
Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Blood Cell Count; Chemotaxis; Female; Humans; Kidney; Liver; Male; Melanoma; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine | 1991 |
6 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Malignant Melanoma
| Article | Year |
|---|---|
Two-dimensional kinetics of beta 2-integrin and ICAM-1 bindings between neutrophils and melanoma cells in a shear flow.
Topics: CD18 Antigens; Cell Adhesion; Cell Aggregation; Cell Line, Tumor; Flow Cytometry; Hemorheology; Humans; Intercellular Adhesion Molecule-1; Kinetics; Melanoma; Models, Biological; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Protein Binding; Stress, Mechanical | 2008 |
In vitro inhibition of interleukin-2-induced defective polymorphonuclear chemotaxis by TNF inhibitor.
Topics: Adult; Antibodies; Bone Marrow Transplantation; Breast Neoplasms; Chemotaxis, Leukocyte; Drug Administration Schedule; Female; Humans; In Vitro Techniques; Infusions, Intravenous; Interleukin-2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Melanoma; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neoplasms; Neutrophils; Recombinant Proteins; Sarcoma; Tumor Necrosis Factor-alpha | 1993 |
Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Chemokine CCL2; Chemotaxis; Female; Humans; Male; Melanoma; Middle Aged; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neoplasm Metastasis; Skin Neoplasms | 1997 |
Prothymosin alpha 1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Chemotaxis, Leukocyte; Cytotoxicity, Immunologic; Female; Humans; Luminescent Measurements; Macrophage-1 Antigen; Male; Melanoma; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Protein Precursors; Reactive Oxygen Species; Receptors, IgG; Thymosin | 1997 |
Effect of tumour necrosis factor alpha in vivo on human granulocyte oxidative metabolism.
Topics: Acridines; Amino Acid Sequence; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Luminescent Measurements; Lymphotoxin-alpha; Melanoma; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidation-Reduction; Recombinant Proteins; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan | 1991 |
In vitro activation of tumoricidal properties in mouse macrophages using the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) incorporated in liposomes.
Topics: Animals; Binding, Competitive; Cell Line; Cytotoxicity, Immunologic; Liposomes; Macrophage Activation; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; N-Formylmethionine Leucyl-Phenylalanine; Peritoneal Cavity; Phagocytosis; Receptors, Formyl Peptide; Receptors, Immunologic | 1988 |